Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar cbbutton (< 20) Submitted: 7/19/2010 6:03:51 PM : Outperform Start Price: $8.49 JAZZ Score: +415.39

Looming FDA approvial

Featured Broker Partners


Advertisement